Similar articles for PMID: 15243278

Year	Number of Results
1993	1
1996	1
1997	1
1998	2
1999	7
2000	3
2001	4
2002	4
2003	5
2004	17
2005	12
2006	9
2007	4
2008	10
2009	8
2010	6
2011	7
2012	7
2013	10
2014	5
2015	5
2016	7
2017	3
2018	6
2019	7
2020	4
2021	7
2022	5
2024	0

1

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis.

Luckey M, Kagan R, Greenspan S, Bone H, Kiel RD, Simon J, Sackarowitz J, Palmisano J, Chen E, Petruschke RA, de Papp AE. Luckey M, et al. Menopause. 2004 Jul-Aug;11(4):405-15. doi: 10.1097/01.gme.0000119981.77837.1f. Menopause. 2004. PMID: 15243278 Clinical Trial.

2

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.

Ettinger B, San Martin J, Crans G, Pavo I. Ettinger B, et al. J Bone Miner Res. 2004 May;19(5):745-51. doi: 10.1359/JBMR.040117. Epub 2004 Jan 19. J Bone Miner Res. 2004. PMID: 15068497 Free article. Clinical Trial.

3

Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis.

Sanad Z, Ellakwa H, Desouky B. Sanad Z, et al. Climacteric. 2011 Jun;14(3):369-77. doi: 10.3109/13697137.2010.537408. Epub 2011 Jan 23. Climacteric. 2011. PMID: 21254911 Clinical Trial.

4

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.

Johnell O, Scheele WH, Lu Y, Reginster JY, Need AG, Seeman E. Johnell O, et al. J Clin Endocrinol Metab. 2002 Mar;87(3):985-92. doi: 10.1210/jcem.87.3.8325. J Clin Endocrinol Metab. 2002. PMID: 11889149 Free article. Clinical Trial.

5

Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study.

Hosking D, Adami S, Felsenberg D, Andia JC, Välimäki M, Benhamou L, Reginster JY, Yacik C, Rybak-Feglin A, Petruschke RA, Zaru L, Santora AC. Hosking D, et al. Curr Med Res Opin. 2003;19(5):383-94. doi: 10.1185/030079903125002009. Curr Med Res Opin. 2003. PMID: 13678475 Clinical Trial.

6

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.

Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, Kagan R, Chen E, Petruschke RA, Thompson DE, de Papp AE; Fosamax Actonel Comparison Trial Investigators. Rosen CJ, et al. J Bone Miner Res. 2005 Jan;20(1):141-51. doi: 10.1359/JBMR.040920. Epub 2004 Sep 29. J Bone Miner Res. 2005. PMID: 15619680 Free article. Clinical Trial.

7

Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.

Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L. Li M, et al. Menopause. 2013 Jan;20(1):72-8. doi: 10.1097/gme.0b013e31825fe2e8. Menopause. 2013. PMID: 22968256 Clinical Trial.

8

Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene.

Cosman F, Keaveny TM, Kopperdahl D, Wermers RA, Wan X, Krohn KD, Krege JH. Cosman F, et al. J Bone Miner Res. 2013 Jun;28(6):1328-36. doi: 10.1002/jbmr.1853. J Bone Miner Res. 2013. PMID: 23281041 Free article. Clinical Trial.

9

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.

Meunier PJ, Vignot E, Garnero P, Confavreux E, Paris E, Liu-Leage S, Sarkar S, Liu T, Wong M, Draper MW. Meunier PJ, et al. Osteoporos Int. 1999;10(4):330-6. doi: 10.1007/s001980050236. Osteoporos Int. 1999. PMID: 10692984 Clinical Trial.

10

Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international.

Reid DM, Hosking D, Kendler D, Brandi ML, Wark JD, Weryha G, Marques-Neto JF, Gaines KA, Verbruggen N, Melton ME. Reid DM, et al. Clin Drug Investig. 2006;26(2):63-74. doi: 10.2165/00044011-200626020-00002. Clin Drug Investig. 2006. PMID: 17163237 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

148 results

Results by year